Accendra Health Inc (ACH) - Total Assets

Latest as of March 2026: $2.42 Billion USD

Based on the latest financial reports, Accendra Health Inc (ACH) holds total assets worth $2.42 Billion USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Accendra Health Inc - Total Assets Trend (1985–2025)

This chart illustrates how Accendra Health Inc's total assets have evolved over time, based on quarterly financial data. Also see ACH company net worth for the company's overall valuation and market capitalisation.

Accendra Health Inc - Asset Composition Analysis

Current Asset Composition (December 2025)

Accendra Health Inc's total assets of $2.42 Billion consist of 22.4% current assets and 77.7% non-current assets. Review ACH total liabilities to assess the company's total debt and financial obligations.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $281.99 Million 11.5%
Accounts Receivable $95.91 Million 3.9%
Inventory $74.44 Million 3.0%
Property, Plant & Equipment $365.26 Million 14.9%
Intangible Assets $136.47 Million 5.6%
Goodwill $1.23 Billion 50.1%

Asset Composition Trend (1985–2025)

This chart illustrates how Accendra Health Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See latest Accendra Health Inc stock price today for real-time trading data and today's change.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Accendra Health Inc's current assets represent 22.4% of total assets in 2025, a decrease from 90.2% in 1985.
  • Cash Position: Cash and equivalents constituted 11.5% of total assets in 2025, up from 2.7% in 1985.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 55.0% of total assets, an increase from 0.0% in 1985.
  • Asset Diversification: The largest asset category is goodwill at 50.1% of total assets.

Accendra Health Inc Competitors by Total Assets

Key competitors of Accendra Health Inc based on total assets are shown below.

Company Country Total Assets
Sigma Healthcare Limited
F:S5YA
Germany €1.83 Billion
China National Medicines Corp Ltd
SHG:600511
China CN¥35.13 Billion
China National Accord Medicines Corp Ltd
SHE:200028
China HK$49.12 Billion
Sigma Healthcare Ltd
AU:SIG
Australia AU$8.74 Billion
Ebos Group Ltd
AU:EBO
Australia AU$8.80 Billion
Mayne Pharma Group Ltd
AU:MYX
Australia AU$1.01 Billion
Paragon Care Ltd
AU:PGC
Australia AU$1.31 Billion
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
Brazil R$5.64 Billion

Accendra Health Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.49 1.13 1.67
Quick Ratio 0.43 0.41 0.61
Cash Ratio 0.00 0.03 0.00
Working Capital $-614.60 Million $245.98 Million $966.90 Million

Accendra Health Inc - Advanced Valuation Insights

This section examines the relationship between Accendra Health Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.07
Latest Market Cap to Assets Ratio 0.03
Asset Growth Rate (YoY) -47.3%
Total Assets $2.45 Billion
Market Capitalization $84.85 Million USD

Valuation Analysis

Below Book Valuation: The market values Accendra Health Inc's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Accendra Health Inc's assets decreased by 47.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Accendra Health Inc (1985–2025)

The table below shows the annual total assets of Accendra Health Inc from 1985 to 2025.

Year Total Assets Change
2025-12-31 $2.45 Billion -47.34%
2024-12-31 $4.66 Billion -8.58%
2023-12-31 $5.09 Billion -5.44%
2022-12-31 $5.39 Billion +52.30%
2021-12-31 $3.54 Billion +6.02%
2020-12-31 $3.34 Billion -8.44%
2019-12-31 $3.64 Billion -3.46%
2018-12-31 $3.77 Billion +11.77%
2017-12-31 $3.38 Billion +24.23%
2016-12-31 $2.72 Billion -2.16%
2015-12-31 $2.78 Billion +1.55%
2014-12-31 $2.74 Billion +17.70%
2013-12-31 $2.32 Billion +5.27%
2012-12-31 $2.21 Billion +13.40%
2011-12-31 $1.95 Billion +6.85%
2010-12-31 $1.82 Billion +4.29%
2009-12-31 $1.75 Billion -1.97%
2008-12-31 $1.78 Billion +17.63%
2007-12-31 $1.52 Billion -10.12%
2006-12-31 $1.69 Billion +35.96%
2005-12-31 $1.24 Billion +9.54%
2004-12-31 $1.13 Billion +8.23%
2003-12-31 $1.05 Billion +3.59%
2002-12-31 $1.01 Billion +5.83%
2001-12-31 $953.85 Million +9.95%
2000-12-31 $867.55 Million +0.29%
1999-12-31 $865.00 Million +20.51%
1998-12-31 $717.80 Million +0.73%
1997-12-31 $712.60 Million +4.87%
1996-12-31 $679.50 Million -20.79%
1995-12-31 $857.80 Million -1.24%
1994-12-31 $868.60 Million +159.83%
1993-12-31 $334.30 Million +21.79%
1992-12-31 $274.50 Million -11.96%
1991-12-31 $311.80 Million +7.44%
1990-12-31 $290.20 Million +12.18%
1989-12-31 $258.70 Million +36.23%
1988-12-31 $189.90 Million +22.99%
1987-12-31 $154.40 Million +21.77%
1986-12-31 $126.80 Million +30.99%
1985-12-31 $96.80 Million --

About Accendra Health Inc

NYSE:ACH USA Medical Distribution
Market Cap
$84.85 Million
Market Cap Rank
#19895 Global
#4546 in USA
Share Price
$1.11
Change (1 day)
-0.89%
52-Week Range
$0.95 - $3.89
All Time High
$3.89
About

Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level pos… Read more